HANNAH HALL: Open Payments
NPI 1124343934 · SHERIDAN, WY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$406 in 20 payments from 9 companies in 2025. Trend: 2023 $444 · 2024 $603 · 2025 $406
Food & beverage: $406
| Company | Payments | Amount |
|---|---|---|
| Insmed, Inc. | 3 | $83 |
| Lilly USA, LLC | 5 | $79 |
| Novo Nordisk Inc | 4 | $72 |
| Astellas Pharma US Inc | 2 | $55 |
| AstraZeneca Pharmaceuticals LP | 2 | $34 |
| ABBVIE INC. | 1 | $27 |
| PFIZER INC. | 1 | $21 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $18 |
| Amgen Inc. | 1 | $18 |
Products named: Arikayce, MOUNJARO, Wegovy, Veozah, QULIPTA, NURTEC ODT, Kerendia, EVENITY.
Industry payments across WY — which companies pay providers there.
